05/14/2025
7:59 AM | CNS Pharmaceuticals (Filer)
| Form 424B4 | |
05/13/2025
11:15 PM | CNS Pharmaceuticals (Filer)
| Form EFFECT | |
05/12/2025
5:03 AM | CNS Pharmaceuticals (Filer)
| Form S-1/A | |
04/09/2025
2:32 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2025
4:11 PM | CNS Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/31/2025
4:12 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2025
4:17 PM | CNS Pharmaceuticals (Filer)
| Form 424B5 | |
03/20/2025
4:15 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2025
4:00 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2024
11:24 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
3:19 PM | CNS Pharmaceuticals (Filer)
| Form DEFR14A | |
Get the Latest News and Ratings for CNSP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for CNS Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
11/01/2024
8:00 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
3:15 PM | CNS Pharmaceuticals (Filer)
| Form DEF 14A | |
10/24/2024
4:27 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
10:23 AM | CNS Pharmaceuticals (Filer)
| Form 424B5 | |
10/23/2024
7:02 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
4:24 PM | CNS Pharmaceuticals (Filer)
| Form PRE 14A | |
09/12/2024
7:58 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
4:22 PM | CNS Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024
6:30 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
4:11 PM | CNS Pharmaceuticals (Issuer)
Cortice Biosciences, Inc. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:53 PM | CNS Pharmaceuticals (Issuer)
Cortice Biosciences, Inc. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/04/2024
11:15 PM | CNS Pharmaceuticals (Filer)
| Form EFFECT | |
07/31/2024
11:32 AM | CNS Pharmaceuticals (Filer)
| Form RW | |
07/30/2024
4:13 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
4:15 PM | CNS Pharmaceuticals (Filer)
| Form 424B3 | |
07/30/2024
6:00 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
7:30 AM | CNS Pharmaceuticals (Filer)
| Form 424B5 | |
07/26/2024
7:00 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2024
8:30 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
4:12 PM | CNS Pharmaceuticals (Filer)
| Form S-1/A | |
07/12/2024
3:30 PM | CNS Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
07/11/2024
6:38 PM | CNS Pharmaceuticals (Filer)
| Form 8-K/A | |
07/09/2024
10:25 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2024
8:49 AM | CNS Pharmaceuticals (Filer)
| Form 424B5 | |
07/03/2024
3:56 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
11:34 AM | CNS Pharmaceuticals (Subject)
Forster Robert (Filed by)
| Form SC 13G | |
06/27/2024
9:00 AM | CNS Pharmaceuticals (Filer)
| Form 424B5 | |
06/26/2024
4:25 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
6:19 PM | CNS Pharmaceuticals (Subject)
Forster Robert (Filed by)
| Form SC 13G | |
06/20/2024
4:00 PM | CNS Pharmaceuticals (Filer)
| Form 8-K/A | |
Trump + Musk = AI’s turning point (Ad) Trump may not code… but he knows how to pick winners.
And according to insiders, his administration is preparing to fast-track a new class of AI infrastructure tech.
Elon Musk has already poured $51 million into it. Chris Rowe just shared the full details in a live presentation… Watch it here before it comes down. |
06/17/2024
10:17 AM | CNS Pharmaceuticals (Filer)
| Form 424B5 | |
06/14/2024
4:25 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy CNSP Stock Free CNSP Stock Alerts